These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9817646)

  • 21. [Percutaneous transluminal coronary angioplasty for restenosis following Palmaz-Schatz stenting: larger size balloons are more effective?].
    Kishi K; Hiasa Y; Suzuki N; Miyamoto H; Takahashi T; Hosokawa S; Tanimoto M; Otani R
    J Cardiol; 1999 Aug; 34(2):55-60. PubMed ID: 10466086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary antithrombotic strategies in patients undergoing coronary stent implantation.
    Bartorelli AL; Trabattoni D
    Minerva Cardioangiol; 2002 Oct; 50(5):517-30. PubMed ID: 12384634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covered stents: a review.
    Jamshidi P; Mahmoody K; Erne P
    Int J Cardiol; 2008 Nov; 130(3):310-8. PubMed ID: 18672301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New strategies in the treatment of restenosis].
    von Hodenberg E; Tost B; Scheffold T
    Z Kardiol; 2000; 89 Suppl 7():19-22. PubMed ID: 11098555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of molecular events in coronary restenosis using coated stents: The Mayo Clinic Approach.
    Keelan PC; Miyauchi K; Caplice NM; Ashai KH; Schwartz RS
    Semin Interv Cardiol; 1998; 3(3-4):211-5. PubMed ID: 10406696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does platelet glycoprotein IIb/IIIa receptor antibody improve in-hospital outcome of coronary stenting in high-risk thrombus containing lesions?
    Piamsomboon C; Wong PM; Mathur A; Singh D; Liu MW; Baxley WA; Iyer SS; Dean LS; Roubin GS
    Catheter Cardiovasc Interv; 1999 Apr; 46(4):415-20. PubMed ID: 10216005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TCT Daily: safety profile of drug-eluting stents similar to bare-metal stents: lower restenosis rates associated with DES.
    Kahn J
    J Interv Cardiol; 2007 Feb; 20(1):30-1. PubMed ID: 17300395
    [No Abstract]   [Full Text] [Related]  

  • 28. Late thrombosis of a drug-eluting stent presenting in the perioperative period.
    de Souza DG; Baum VC; Ballert NM
    Anesthesiology; 2007 May; 106(5):1057-9. PubMed ID: 17457140
    [No Abstract]   [Full Text] [Related]  

  • 29. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
    Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME;
    J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and feasibility of coronary stenting during rescue PTCA: in-hospital outcome.
    Repetto S; Castiglioni B; Boscarini M; Balian V; Vaninetti R; Binaghi G
    G Ital Cardiol; 1999 Jun; 29(6):630-6. PubMed ID: 10396666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic impact on physicians and hospitals of proposed changes in Medicare reimbursement for coronary interventions.
    Vaitkus PT
    Am Heart J; 1999 Feb; 137(2):258-63. PubMed ID: 9924159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Can radiotherapy reduce the frequency of restenosis after coronary angioplasty?].
    Langberg CW; Solheim S; Hagen S
    Tidsskr Nor Laegeforen; 2000 Feb; 120(6):707-10. PubMed ID: 10806885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [State of treatment of coronary artery disease by drug releasing stents].
    Müller R; Büllesfeld L; Gerckens U; Grube E
    Herz; 2002 Sep; 27(6):508-13. PubMed ID: 12378395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.
    Agema WR; Monraats PS; Zwinderman AH; De Winter RJ; Tio RA; Doevendans PA; Waltenberger J; De Maat MP; Frants RR; Atsma DE; Van Der Laarse A; Van Der Wall EE; Jukema JW
    Eur Heart J; 2004 Jul; 25(13):1163-70. PubMed ID: 15231375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Concepts for local therapy of restenosis].
    Riessen R; Oberhoff M; Karsch KR
    Z Kardiol; 1996; 85 Suppl 1():87-98. PubMed ID: 8882829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gene therapy of restenosis].
    Steg PG; Feldman L
    Pathol Biol (Paris); 1998 Mar; 46(3):201-4. PubMed ID: 9769916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: Intracoronary emergency stenting: complications and experiences with 124 patients. U. Rissel et al.: Z Kardiol 83: 327-335 (1994).
    Sigwart U
    Z Kardiol; 1995 Jun; 84(6):499. PubMed ID: 7653092
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intracoronary brachytherapy after PTCA: current clinical position].
    Silber S
    Dtsch Med Wochenschr; 1999 Dec; 124(49):1491-5. PubMed ID: 10629668
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravascular stents.
    Chapman GD; Gammon RS; Bauman RP; Stack RS
    Trends Cardiovasc Med; 1991 Apr; 1(3):127-31. PubMed ID: 21239328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.